GLIMITERIS M1

GLIMITERIS M1 is a combination medication specifically formulated for the effective management of type 2 diabetes. It contains Glimepiride, a sulfonylurea, and Metformin Hydrochloride, a biguanide, in a prolonged-release form. This dual-action tablet helps in maintaining optimal blood glucose levels throughout the day.

How Does It Work?

• Glimepiride: Stimulates the pancreas to secrete insulin, which helps lower blood sugar levels.
• Metformin Hydrochloride: Reduces glucose production in the liver and enhances insulin sensitivity, allowing the body to utilize glucose more effectively.

Uses

• Type 2 Diabetes Management: Assists in controlling blood sugar levels in patients with type 2 diabetes.
• Improved Glycemic Control: Provides better overall blood glucose regulation by combining two different mechanisms of action.

What is GLIMITERIS M1?

GLIMITERIS M1 is a prolonged-release oral antidiabetic medication combining Glimepiride and Metformin Hydrochloride. This combination offers a comprehensive approach to managing type 2 diabetes by addressing both insulin secretion and glucose production/utilization.

Side Effects

• Common: Hypoglycemia, gastrointestinal issues (nausea, diarrhea, abdominal pain), dizziness.
• Serious: Lactic acidosis (rare but serious), severe hypoglycemia, allergic reactions.

Safety Information

• Monitoring: Regularly monitor blood sugar levels to avoid hypoglycemia.
• Diet and Exercise: Follow a healthy diet and exercise routine as recommended by your healthcare provider.
• Interactions: Inform your doctor about all medications and supplements you are taking to prevent potential interactions.
• Pregnancy and Breastfeeding: Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding.

If You Need More Information About  GLIMITERIS M1 Click here